The largest database of trusted experimental protocols

162 protocols using vivid 1

1

Brachial Artery Vasodilation Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Brachial artery FMD and nitroglycerin-mediated vasodilation (NMD) were measured by ultrasound (Vivid I, GE) in combination with an automated analysis system (Brachial Analyzer, MIA, Iowa City) as described (Heiss et al. 2010a (link)). Brachial artery (BA) FMD was measured by ultrasound (10-MHz transducer; Vivid I, GE) in combination with an automated analysis system (Brachial Analyzer, MIA, Iowa City, IO) in a 21 °C-temperature-controlled room after 15 min of supine rest. Diameter and Doppler-flow velocity were measured at baseline and immediately after cuff deflation, at 20, 40, 60, and 80 s, and maximal diameter was used to calculate FMD. At the end of each study day, nitroglycerin-mediated vasodilation (NMD) was measured at 4 min after 400 μg sublingual nitroglycerin (Nitrolingual, Pohl).
+ Open protocol
+ Expand
2

Comparative evaluation of a novel ultrasound device

Check if the same lab product or an alternative is used in the 5 most similar protocols

A laboratory ex vivo trial (Fig. 4), where layered samples thicknesses (brain on muscle and vice versa, from a young porcine) were measured and compared with the NUD and an US imaging system (GE VIVIDI, or BK Medical, or Sonowand). The measuring set-up of this ex vivo laboratory experiment is described in Fig. 4. On the left side of Fig. 4 is placed the US imaging system (GE, type VIVIDI, where in other lab experiments, BK Medical, or Sonowand were applied); a prototype of the NUD is presented in the middle of this figure and on its right side—the mechanical system that enables the movement (sliding) of the handpiece in the x, y, and z directions.

Clinical human neurosurgical trials are presented, where we compared tumor depths, as measured with the NUD and an US imagining instrument (BK Medical or Sonowand), which are an integrated part of the operating room (OR);

Assessing tumor’s residual thickness during its resection. These measurements were performed solely with the NUD, after we obtained good correlations in stages (i) and (ii). Moreover, it was not feasible to stop resection, in order to pore NS in a restricted area, in order to obtain a good US conductivity and applying an US imaging transducer.

The measuring set-up of the laboratory ex vivo experiment

+ Open protocol
+ Expand
3

Ultrasound Assessment of Carotid Intima-Media Thickness

Check if the same lab product or an alternative is used in the 5 most similar protocols
Using an ultrasound device (GE, Vivid I®, California, United States) a trained sonographer obtained images of the left common carotid artery (GE, Vivid I®, California, United States), following published guidelines (Touboul et al., 2012 (link)). A linear array transducer (10 MHZ) was used to obtain longitudinal images of the common carotid artery, approximately 2 cm from the carotid bulb. Images with clear definitions of the near and far walls of the artery were used to measure the cIMT at end diastole. The far-wall intima-lumen and media-adventitia interfaces were identified, and a total of six manual measurements were completed. The average of the six measurements was used as the cIMT in micrometres (µm). During the assessment, participants were in a supine position with their neck extended and their head tilted at ∼45° degrees.
+ Open protocol
+ Expand
4

Carotid Intima-Media Thickness and Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
Intima–media thickness (IMT) in the carotid artery was measured using high-resolution, real-time ultrasonography with a 7.5 MHz transducer (Vivid I or LOGIQ e, GE, Tokyo, Japan). Measurements of the arterial wall thickness were performed on four segments of the bilateral carotid arteries: at 1.5 cm distal to the bifurcation in the internal carotid artery (S1), at the bifurcation (S2), at 0–1.5 cm (S3), and 1.5–3.0 cm (S4) proximal to the bifurcation in the common carotid artery. The maximal value among the 8 measurements on S1–S4 of the bilateral carotid arteries served as max-IMT in the present study. Eight measurements at S1–S4 of the bilateral carotid arteries were summed up as plaque score (PS) if they were 1.1 cm or more.
Venous blood was collected after overnight fasting. The plasma sample was separated within 30 min of the blood being drawn and kept frozen at −80 °C until the measurement of carnitine-related metabolites, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).
+ Open protocol
+ Expand
5

Cardiac Shock Wave Therapy Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients were maintained on stable doses of medications [19 (link)] for 4 weeks before the baseline evaluation and the entire study period. CSWT was performed using Cardiospec device (Medispec Ltd., Germantown, Maryland, USA) coupled with a cardiac ultrasound imaging system (Vivid I; GE Healthcare, Horten, Norway) to target the treatment area under ECG R-wave gating. Treatment consisted of 9 sessions with 3 sessions per week and was performed on the first, fifth, and the ninth study weeks. Treatment intensity was equal to 100 impulses applied to one spot with up to 1200 impulses to the patient per session. During the first, fifth, and the ninth study weeks, SWs were delivered to the basal, middle, and apical segments of the left ventricle (LV), respectively, covering the whole LV [18 ].
+ Open protocol
+ Expand
6

Carotid Intima-Media Thickness Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
We evaluated the cIMT at baseline and at 6 and 12 months in all patients. All ultrasound measurements were of the common and internal carotid artery walls and were performed by using a GE Vivid I device with 7-MHz linear array transducer. The images obtained were evaluated according to the Mannheim Carotid Intima–Media Thickness Consensus (2004–06) [14 (link)]. The cIMT was measured from multiple segments of the posterior wall of both sides of the common carotid artery at 1 cm before the bifurcation in the longitudinal view. With use of computer software, the mean value, maximum and SD of cIMT were calculated. For the analysis, the dependent variable was the mean of cIMT on both sides. All measures were evaluated by a single researcher, who was blinded to the groups.
+ Open protocol
+ Expand
7

Echocardiography Evaluation of Rat Cardiac Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
Left ventricular function was determined using an echocardiography (GE Vivid I) [50 (link)]. Rats were lightly inducted and maintained with 2% isoflurane with oxygen (2 L/min) inhalation. Their chest areas were shaved and the rats were stabilized for 1–2 minutes in the supine position prior to starting the protocol. The probe was gently placed on the chest and moved to enable the collection of data along the short and long axes of the heart. Signals from M-mode echocardiography at the level of the papillary muscles were recorded. Parameters from the echocardiograph, including left ventricular internal diameter end systole (LVIDs) and end diastole (LVIDd), were recorded. Fractional shortening was calculated by using the following formula: %FS = (LVIDd−LVIDs) x 100 /LVIDd [50 (link)].
+ Open protocol
+ Expand
8

Echocardiography Assessment of Cardiac Function in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
On the 15th day of the experiment, the rats were anaesthetized with 2% isoflurane using a small-animal inhalation gas anaesthesia machine (Midmark Group, Inc. no. VMR). Echocardiography was performed with a high-end portable colour doppler diagnostic instrument (GE Medical Systems Israel Ltd. Israel, no. VIVID I). Cardiac function was assessed by estimating the left ventricular internal diameter at end-diastole (LVIDd), left ventricular internal diameter at end-systole (LVIDs), left ventricular fractional shortening (FS%), and ejection fraction (EF%).
+ Open protocol
+ Expand
9

Echocardiographic Evaluation of Rat Cardiac Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rats were anesthetized by isoflurane inhalation (2% isoflurane, 98% O2) and left ventricular function was assessed by two-dimensional echocardiography using a 12.5-MHz probe (Vivid i, GE Health Care). All measurements were performed in accordance with the conventions of the American Society of Echocardiography and were conducted by the same trained, blinded sonographer. Left ventricular function was visually scanned by B-mode imaging in short and long parasternal axis. Measurement of left systolic and diastolic ventricular wall thicknesses and diameters as well as measurement of aortal and left atrial diameters was performed in long parasternal axis by M-Mode imaging. Fractional shortening (FS) was calculated as FS = (LVEDD-LVESD/LVEDD) × 100, where LVEDD and LVESD are LV internal diameters in end-diastole and end-systole, respectively. Fractional shortening (% FS) and left ventricular ejection fraction (% EF) were calculated from mean-values of 6 independently performed measurements per setting. Pulsed wave (PW) doppler was used to assess transmitral valve flow velocities during early (E) and atrial (A) filling periods.
+ Open protocol
+ Expand
10

Standardized Transthoracic Echocardiography Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three trained echocardiographers obtained resting transthoracic echocardiograms in all participants visiting the research center. The standardized protocol included 2-dimensional scanning in the parasternal long and short axis views, apical and subcostal views. In addition, left ventricular dimensions were measured using 2-dimension guided M-mode. Tricuspid regurgitation peak velocity (TRV) was measured using Continuous Wave Doppler. Tissue Doppler imaging was done in the apical 4-chamber view.
Echocardiograms were made using a commercially available ultrasonography system (Vivid I, GE Healthcare, Little Chalfont, UK), with a 2.5 MHz transducer. All images obtained were digitally stored and assessed offline by the echocardiographers. Abnormal findings were confirmed by clinical experts and communicated to the participants and their general practitioners according to a pre-defined protocol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!